Only 2 New Alzheimer’s Drugs Approved in 20 Years: What’s Going Wrong?
Despite $2.6 billion in funding, only 2 new Alzheimer’s drugs were approved in two decades, highlighting systemic failures in biotech.
Alzheimer’s research
Only 1 Drug Approved in 20 Years: What’s Holding Back Alzheimer’s Research?
By Dana Kim, Crypto Markets Analyst Last updated: April 26, 2026 Only 1 Drug Approved in 20 Years: What’s Holding Back Alzheimer’s Research? Over the past 20 years, only one drug for Alzheimer’s disease has gained FDA approval, a shocking figure given the escalating costs and urgent need for effective treatments. The financial intensity of … Read more